These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 28870801)
1. Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f][1,7]naphthyrdines. Arepalli SK; Park B; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H Bioorg Med Chem; 2017 Oct; 25(20):5586-5597. PubMed ID: 28870801 [TBL] [Abstract][Full Text] [Related]
2. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors. Arepalli SK; Lee C; Sim S; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H Bioorg Med Chem; 2018 Oct; 26(18):5181-5193. PubMed ID: 30253887 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation, structure-activity relationship study, and mode of action of 2-phenol-4,6-dichlorophenyl-pyridines. Shrestha A; Park S; Shin S; Man Kadayat T; Bist G; Katila P; Kwon Y; Lee ES Bioorg Chem; 2018 Sep; 79():1-18. PubMed ID: 29715635 [TBL] [Abstract][Full Text] [Related]
5. Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity. Bist G; Park S; Song C; Thapa Magar TB; Shrestha A; Kwon Y; Lee ES Eur J Med Chem; 2017 Jun; 133():69-84. PubMed ID: 28384547 [TBL] [Abstract][Full Text] [Related]
6. Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors. Park S; Kadayat TM; Jun KY; Thapa Magar TB; Bist G; Shrestha A; Lee ES; Kwon Y Eur J Med Chem; 2017 Jan; 125():14-28. PubMed ID: 27643560 [TBL] [Abstract][Full Text] [Related]
7. 4-Flourophenyl-substituted 5H-indeno[1,2-b]pyridinols with enhanced topoisomerase IIα inhibitory activity: Synthesis, biological evaluation, and structure-activity relationships. Kunwar S; Hwang SY; Katila P; Seo M; Man Kadayat T; Kwon Y; Lee ES Bioorg Chem; 2021 Nov; 116():105349. PubMed ID: 34536927 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors. Karki R; Park C; Jun KY; Jee JG; Lee JH; Thapa P; Kadayat TM; Kwon Y; Lee ES Eur J Med Chem; 2014 Sep; 84():555-65. PubMed ID: 25062006 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics. Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968 [TBL] [Abstract][Full Text] [Related]
10. Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor. Kadayat TM; Park C; Jun KY; Thapa Magar TB; Bist G; Yoo HY; Kwon Y; Lee ES Eur J Med Chem; 2015 Jan; 90():302-14. PubMed ID: 25437617 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622 [TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor. Park S; Thapa Magar TB; Kadayat TM; Lee HJ; Bist G; Shrestha A; Lee ES; Kwon Y Eur J Med Chem; 2017 Feb; 127():318-333. PubMed ID: 28068603 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor. Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors. Subba Rao AV; Vishnu Vardhan MV; Subba Reddy NV; Srinivasa Reddy T; Shaik SP; Bagul C; Kamal A Bioorg Chem; 2016 Dec; 69():7-19. PubMed ID: 27656775 [TBL] [Abstract][Full Text] [Related]
16. Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2- Kadayat TM; Park S; Shrestha A; Jo H; Hwang SY; Katila P; Shrestha R; Nepal MR; Noh K; Kim SK; Koh WS; Kim KS; Jeon YH; Jeong TC; Kwon Y; Lee ES J Med Chem; 2019 Sep; 62(17):8194-8234. PubMed ID: 31398033 [TBL] [Abstract][Full Text] [Related]
17. A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. Karki R; Jun KY; Kadayat TM; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Eur J Med Chem; 2016 May; 113():228-45. PubMed ID: 26945111 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors. Han X; Zhong Y; Zhou G; Qi H; Li S; Ding Q; Liu Z; Song Y; Qiao X Bioorg Med Chem; 2017 Jun; 25(12):3116-3126. PubMed ID: 28462840 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors. Ibrahim MK; Taghour MS; Metwaly AM; Belal A; Mehany ABM; Elhendawy MA; Radwan MM; Yassin AM; El-Deeb NM; Hafez EE; ElSohly MA; Eissa IH Eur J Med Chem; 2018 Jul; 155():117-134. PubMed ID: 29885574 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents. Magar TBT; Seo SH; Kadayat TM; Jo H; Shrestha A; Bist G; Katila P; Kwon Y; Lee ES Bioorg Med Chem; 2018 May; 26(8):1909-1919. PubMed ID: 29510948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]